Market Research Logo

Global Gene Expression Analysis Market - Segmented by Technology, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)

Global Gene Expression Analysis Market - Segmented by Technology, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)

The global gene expression analysis market for the period 2018-2023 is expected to account high CAGR of 5.8%. Gene expression profiling is the measurement of the activity (the expression) of thousands of genes at once, and creates a global picture of cellular function.

Growth in Personalized Medicine

Personalized medicine, the ability to tailor diagnostic and treatment decisions for individual patients, is seen as the evolution of modern medicine. Diagnosis, treatment, and lifestyle interventions will be increasingly personalized to individual patient genetics, family history and other factors. Technologies are making it easier for healthcare professionals to track patient health information and provide personalized care. Personalized medicine is becoming more popular with the growing number of genetic disorders. Also, the increasing awareness about such a form of treatment will help drive the market to quite a high growth rate in the future. The growing technological advancement such as NGS and molecular services are augmenting the demand for gene expression services. Additionally, development of genomic databases, increased government funding towards genomics, and growth in personalized medicine are likely to drive the market.

Lack of Skilled Labor

Accessibility of skilled labor is vital for innovation in firms. The contribution of skilled labor can lead to innovation and growth by generation new knowledge and developing incremental innovations, Although, educational attainment has risen steadily in OECD countries in past decades, innovating firms still suffer from a shortage of skilled labor, inhibiting their capacity to innovate. This trend is common in the gene expression analysis market. This, along with other factors, such as, high cost of instruments will lead to the decline of the market in the forecast period.

North America to Dominate the Market

North America accounted for the largest share of the gene expression analysis market and is expected to grow at the fastest rate during the forecast period. Growth in this region can be attributed to increasing research activities on agriculture, government intervention to improve healthcare, and rising popularity of gene expression tests. Asia-Pacific is also expected to witness high growth owing to growing investment from governments in the field of genomics.

Key Developments in the Market

  • February 2018: FDA Cleared Roche Factor II, Factor V Gene Mutation Test for Inherited Thrombophilia. Factor V test for use on the Cobas 4800 system, which performs real-time PCR analysis for mid- to high-volume labs
Major Players: BIO-RAD LABORATORIES, GE HEALTHCARE, LIFE TECHNOLOGIES, PERKINELMER, QIAGEN, ROCHE DIAGNOSTICS, AFFYMETRIX, amongst others.

Reasons to Purchase this Report
  • Current and future global gene expression analysis market outlook in the developed and emerging markets
  • Analysis of various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3 months analyst support, along with the Market Estimate sheet ((in Excel).
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.


1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rapid Technological Advancement
6.1.2 Development of Genomic Databases
6.1.3 Increased Government Funding towards Genomics
6.1.4 Growth in Personalized Medicine
6.2 Market Restraints
6.2.1 Lack of Skilled Labor
6.2.2 High Cost of Instruments
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Technology
7.1.1 Polymerase Chain Reaction (PCR)
7.1.2 Next Generation Sequencing (NGS)
7.1.3 Microarray
7.1.4 Sanger Sequencing
7.1.5 Others
7.2 By Application
7.2.1 Drug Discovery
7.2.2 Diagnostic Laboratories
7.2.3 Academic Research Centers
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United Kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 China
7.3.3.2 Japan
7.3.3.3 India
7.3.3.4 Australia & New Zealand
7.3.3.5 South Korea
7.3.3.6 Rest of Asia-Pacific
7.3.4 Middle East & Africa
7.3.4.1 GCC
7.3.4.2 South Africa
7.3.4.3 Rest of the Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Affymetrix
9.2 Bio-Rad Laboratories
9.3 GE Healthcare
9.4 Life Technologies
9.5 PerkinElmer
9.6 Qiagen
9.7 Roche Diagnostics
9.8 List Not Exhaustive
10. Future of the Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report